Publications by authors named "Monique Claudon"

Claim this Profile
T
The β-lactamase inhibitor avibactam (NXL104) does not induce ampC β-lactamase in Enterobacter cloacae.
Christine Miossec, Monique Claudon, Premavathy Levasseur, Michael T Black

Infect Drug Resist· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro antibacterial activity of the ceftazidime-avibactam (NXL104) combination against Pseudomonas aeruginosa clinical isolates.
Premavathy Levasseur, Anne-Marie Girard, Monique Claudon, Herman Goossens, Michael T Black

Antimicrob Agents Chemother· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanistic studies of the inactivation of TEM-1 and P99 by NXL104, a novel non-beta-lactam beta-lactamase inhibitor.
Thérèse Stachyra, Marie-Claude Péchereau, Jean-Michel Bruneau, Monique Claudon, Jean-Marie Frère

Antimicrob Agents Chemother· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro activity of the {beta}-lactamase inhibitor NXL104 against KPC-2 carbapenemase and Enterobacteriaceae expressing KPC carbapenemases.
Thérèse Stachyra, Premavathy Levasseur, Marie-Claude Péchereau, Anne-Marie Girard, Monique Claudon

J Antimicrob Chemother· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanism of action of the antibiotic NXL101, a novel nonfluoroquinolone inhibitor of bacterial type II topoisomerases.
Michael T Black, Thérèse Stachyra, Denis Platel, Anne-Marie Girard, Monique Claudon

Antimicrob Agents Chemother· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis